Phase 2 Crohn's Disease and Colitis Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Part A (before starting treatment):

• You have been diagnosed with Inflammatory Bowel Disease (IBD)
• Your IBD is currently active, either based on symptoms measured by standard scoring tools, or shown by a stool test result above a certain level
• Your doctor has determined that a medication called risankizumab is an appropriate treatment option for you
• You are at least 18 years old
• You are willing and able to sign a consent form agreeing to take part
• You already have a medical reason to have a camera procedure (endoscopy) of your bowel

Part B (already on treatment):

• You have been diagnosed with Inflammatory Bowel Disease (IBD)
• You have been taking risankizumab for at least 14 weeks
• You are at least 18 years old
• You are willing and able to sign a consent form agreeing to take part
• You already have a medical reason to have a camera procedure (endoscopy) of your bowel

Who may not be able to join:

• You are pregnant or currently breastfeeding
• You are a woman who has not yet gone through menopause and are not using a reliable form of contraception during the study period and for 10 weeks afterward
• You have a medical or mental health condition that affects your ability to fully understand and agree to taking part in the study
• You have previously been treated with a specific type of medication that targets a protein called IL-23 alone (having had a combination IL-23/IL-12 therapy does not automatically exclude you — confirm with trial site)
• You have active Crohn's disease complications outside the gut, such as certain eye or skin conditions, in sensitive locations (Part A only)

Important: Always verify eligibility with the trial site directly before applying.